530 related articles for article (PubMed ID: 26046681)
1. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma.
Kamatani T; Shiogama S; Yoshihama Y; Kondo S; Shirota T; Shintani S
Cytokine; 2013 Nov; 64(2):497-502. PubMed ID: 24063998
[TBL] [Abstract][Full Text] [Related]
5. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
6. Chronic periodontitis can affect the levels of potential oral cancer salivary mRNA biomarkers.
Cheng YL; Jordan L; Chen HS; Kang D; Oxford L; Plemons J; Parks H; Rees T
J Periodontal Res; 2017 Jun; 52(3):428-437. PubMed ID: 27549383
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of saliva and plasma cytokine biomarkers in patients with oral squamous cell carcinoma.
Lee LT; Wong YK; Hsiao HY; Wang YW; Chan MY; Chang KW
Int J Oral Maxillofac Surg; 2018 Jun; 47(6):699-707. PubMed ID: 29174861
[TBL] [Abstract][Full Text] [Related]
8. Proteomics investigation of OSCC-specific salivary biomarkers in a Hungarian population highlights the importance of identification of population-tailored biomarkers.
Csősz É; Lábiscsák P; Kalló G; Márkus B; Emri M; Szabó A; Tar I; Tőzsér J; Kiss C; Márton I
PLoS One; 2017; 12(5):e0177282. PubMed ID: 28545132
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma.
Arantes DA; Costa NL; Mendonça EF; Silva TA; Batista AC
Arch Oral Biol; 2016 Jan; 61():28-35. PubMed ID: 26513679
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva.
Gonçalves AS; Arantes DA; Bernardes VF; Jaeger F; Silva JM; Silva TA; Aguiar MC; Batista AC
Hum Immunol; 2015 Jan; 76(1):52-8. PubMed ID: 25500427
[TBL] [Abstract][Full Text] [Related]
11. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
12. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages.
Jou YJ; Lin CD; Lai CH; Tang CH; Huang SH; Tsai MH; Chen SY; Kao JY; Lin CW
Clin Chim Acta; 2011 Jul; 412(15-16):1357-65. PubMed ID: 21497587
[TBL] [Abstract][Full Text] [Related]
13. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
14. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
15. Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma.
Vucicević Boras V; Cikes N; Lukać J; Virag M; Cekić-Arambasin A
Minerva Stomatol; 2005 Oct; 54(10):569-73. PubMed ID: 16224376
[TBL] [Abstract][Full Text] [Related]
16. Validation of Salivary Markers, IL-1β, IL-8 and Lgals3bp for Detection of Oral Squamous Cell Carcinoma in an Indian Population.
Singh P; Verma JK; Singh JK
Sci Rep; 2020 Apr; 10(1):7365. PubMed ID: 32355279
[TBL] [Abstract][Full Text] [Related]
17. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma.
Hsu CW; Yu JS; Peng PH; Liu SC; Chang YS; Chang KP; Wu CC
J Proteome Res; 2014 Nov; 13(11):4796-807. PubMed ID: 24708169
[TBL] [Abstract][Full Text] [Related]
18. Measurement of salivary metabolite biomarkers for early monitoring of oral cancer with ultra performance liquid chromatography-mass spectrometry.
Wang Q; Gao P; Cheng F; Wang X; Duan Y
Talanta; 2014 Feb; 119():299-305. PubMed ID: 24401418
[TBL] [Abstract][Full Text] [Related]
19. Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study.
Czerninski R; Basile JR; Kartin-Gabay T; Laviv A; Barak V
Oral Dis; 2014 Jul; 20(5):477-81. PubMed ID: 23859102
[TBL] [Abstract][Full Text] [Related]
20. Correlation between salivary interleukin-6 levels and early locoregional recurrence in patients with oral squamous cell carcinoma: preliminary study.
Sato J; Ohuchi M; Abe K; Satoh T; Abe T; Yamazaki Y; Satoh A; Notani K; Kitagawa Y
Head Neck; 2013 Jun; 35(6):889-94. PubMed ID: 22887132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
